A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 6, 2008, Pages 2100-2104

  Vieillard, Vincent ^a   Le Grand, Roger ^b   Dausset, Jean ^c   Debre, Patrice ^c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3S ANTIBODY; GLYCOPROTEIN; PEPTIDE ANTIBODY; PROTEIN NKP44L; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS; T CELL DEPLETION;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE DEPLETION; MACACA FASCICULARIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 41149137630     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711629105     Document Type: Article

References (28)

1. + T cell depletion in HIV infection: Are we closer to understanding the cause? Nat Med 8:319-323.
2. Gougeon ML (2003) Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3:392-404.
3. Derdeyn CA, Silvestri G (2005) Viral and host factors in the pathogenesis of HIV infection. Curr Opin Immunol 17:366-373.
4. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ (2006) Pathogenesis of HIV infection: What the virus spares is as important as what it destroys. Nat Med 12:289-295.
5. + T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 84:1649-1661.
6. + T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci USA 102:10981-10986.
7. Ward J, et al. (2007) HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T cell blasts. Blood 110:1207-1214.
8. Vieillard V, Costagliola D, Simon A, Debré P (2006) French Asymptomatiques à Long Term (ALT) Study Group specific adaptive humoral response against a gp41 motif inhibits CD4 T cell sensitivity to NK lysis during HIV-1 infection. AIDS 20:1795-1804.
9. Burton DR, et al. (2004) HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5:233-236.
10. Zolla-Pazner S (2004) Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol 4:199-210.
11. Trkola A, et al. (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11:915-922.
12. Nakowitsch S, et al. (2005) HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: In vitro experiments versus clinical studies. AIDS 19:1957-1966.
13. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C (1999) Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284:816-819.
14. Harouse JM, et al. (2001) Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 75:1990-1995.
15. Chan DC, Fass D, Berger JM, Kim PS (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
16. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-430.
17. Wang S, et al. (2002) Interhelical interactions in the gp41 core: Implications for activation of HIV-1 membrane fusion. Biochemistry 41:7283-7292.
18. Fauci AS, Mavilio D, Kottilil S (2005) NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat Rev Immunol 5:835-843.
19. Scott-Algara D, et al. (2003) Cutting edge: Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 171:5663-5667.
20. Scott-Algara D, Paul P (2002) NK cells and HIV infection: Lessons from other viruses. Curr Mol Med 2:757-768.
21. Alter G, Altfeld M (2006) NK cell function in HIV-1 infection. Curr Mol Med 6:621-629.
22. Martin MP, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Gen 39:733-740.
23. Diop OM, et al. (2000) High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 74:7538-7547.
24. Hirsch VM (2004) What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? AIDS Rev 6:40-53.
25. Andre FE (2003) Vaccinology: Past achievements, present roadblocks, and future promises. Vaccine 21:593-595.
26. Plotkin SA (2005) Vaccines: Past, present, and future. Nat Med 11:5-11.
27. Kabir S (2007) Cholera vaccines. Lancet Infect Dis 7:176-178.
28. Dioszeghy V, et al. (2006) J Virol 80:236-245.